Millennium Management’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,721
Closed -$60.8K 6421
2025
Q1
$60.8K Sell
10,721
-3,830
-26% -$18.1K ﹤0.01% 5514
2024
Q4
$72.9K Sell
14,551
-4,705
-24% -$27.8K ﹤0.01% 5533
2024
Q3
$129K Sell
19,256
-2,416
-11% -$19.2K ﹤0.01% 5538
2024
Q2
$208K Buy
+21,672
New +$213K ﹤0.01% 5122
2022
Q4
Sell
-492
Closed -$10K 7137
2022
Q3
$10K Sell
492
-206
-30% -$4.66K ﹤0.01% 6659
2022
Q2
$14K Buy
+698
New +$18.8K ﹤0.01% 6584
2022
Q1
Sell
-373
Closed -$14K 7591
2021
Q4
$14K Buy
+373
New +$10.1K ﹤0.01% 6626
2021
Q2
Sell
-527
Closed -$30K 7210
2021
Q1
$30K Sell
527
-2,450
-82% -$171K ﹤0.01% 5805
2020
Q4
$159K Sell
2,977
-3,777
-56% -$218K ﹤0.01% 4926
2020
Q3
$192 Sell
6,754
-69
-1% -$2.46K ﹤0.01% 4083
2020
Q2
$227K Buy
+6,823
New +$201K ﹤0.01% 3789
2019
Q2
Sell
-2,081
Closed -$296K 4538
2019
Q1
$296K Sell
2,081
-437
-17% -$63.9K ﹤0.01% 3551
2018
Q4
$265K Buy
+2,518
New +$320K ﹤0.01% 3273

Other funds holding SER

Millennium Management's SER Position: Q2 2025 in Review

Millennium Management sold out of Serina Therapeutics (SER) in Q2 2025, closing a stake of 10,721 shares — an estimated $60.8K sold.

Millennium Management first reported a position in SER in Q4 2018 and held it in 13 quarters. The position peaked at $296K in Q1 2019. 23 funds tracked by Wall St. Rank hold SER as of Q2 2025.

  • Millennium Management reported no remaining Serina Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Millennium Management sold 10,721 Serina Therapeutics shares in Q2 2025, an estimated $60.8K.
  • Millennium Management first reported a position in Serina Therapeutics in Q4 2018 and held it in 13 quarters.
  • Millennium Management's Serina Therapeutics position peaked at $296K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.